They reported that EGFR (37.3%) and PTEN (54.9%) mutations are relatively common in primary GBM, while TP53 (66.7%) and IDH1 (44.4%) mutations were more common in secondary GBMs. This evidence concerns the gene EGFR and glioblastoma.